4:03 PM
 | 
Aug 22, 2018
 |  BC Extra  |  Preclinical News

Inhibiting MMP2 reverses leptin resistance associated with obesity

University of California San Diego researchers and colleagues showed that inhibiting cleavage of leptin receptor (LEPR; CD295) by matrix metalloproteinase 2 (MMP2) could help prevent leptin resistance and treat obesity.

Obesity is associated with high circulating concentrations of leptin, a hormone that signals satiety to the brain, but reduced LEPR signaling (known as leptin resistance). However, the molecular mechanisms leading to leptin resistance have...

Read the full 300 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >